Artivion/$AORT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Artivion
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
Ticker
$AORT
Sector
Trading on
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Employees
1,600
ISIN
US2289031005
Website
Artivion Metrics
BasicAdvanced
$1.3B
-
-$0.53
1.54
-
Price and volume
Market cap
$1.3B
Beta
1.54
52-week high
$32.33
52-week low
$21.97
Average daily volume
466K
Financial strength
Current ratio
5.531
Quick ratio
2.569
Long term debt to equity
121.318
Total debt to equity
123.146
Interest coverage (TTM)
0.57%
Management effectiveness
Return on assets (TTM)
1.89%
Return on equity (TTM)
-7.26%
Valuation
Price to revenue (TTM)
3.197
Price to book
4.32
Price to tangible book (TTM)
-11.89
Price to free cash flow (TTM)
-71.523
Growth
Revenue change (TTM)
5.94%
Earnings per share change (TTM)
126.44%
3-year revenue growth (CAGR)
8.55%
3-year earnings per share growth (CAGR)
11.81%
What the Analysts think about Artivion
Analyst ratings (Buy, Hold, Sell) for Artivion stock.
Artivion Financial Performance
Revenues and expenses
Artivion Earnings Performance
Company profitability
Artivion News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Artivion stock?
Artivion (AORT) has a market cap of $1.3B as of May 29, 2025.
What is the P/E ratio for Artivion stock?
The price to earnings (P/E) ratio for Artivion (AORT) stock is 0 as of May 29, 2025.
Does Artivion stock pay dividends?
No, Artivion (AORT) stock does not pay dividends to its shareholders as of May 29, 2025.
When is the next Artivion dividend payment date?
Artivion (AORT) stock does not pay dividends to its shareholders.
What is the beta indicator for Artivion?
Artivion (AORT) has a beta rating of 1.54. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.